Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGolden Pros Regulatory News (GPM)

Share Price Information for Golden Pros (GPM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 34.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (6.061%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 34.00
GPM Live PriceLast checked at -
Golden Prospect Precious Metals is an Investment Trust

To generate above average capital appreciation of its investments through a selective portfolio of securities and other instruments in the precious metals, diamond and uranium sectors.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monthly Investor Report - March 2024

26 Apr 2024 15:01

RNS Number : 2728M
Golden Prospect Precious Metals Ltd
26 April 2024
 

 

 

Golden Prospect Precious Metals Limited

 

Monthly Investor Report - March 2024

 

The full monthly factsheet is now available on the Company's website and a summary can be found below. 

 

NCIM - Golden Prospect Precious Metals Ltd - Fund Page

 

Enquiries: 

 

For the Investment Manager 

CQS (UK) LLP 

Craig Cleland 

0207 201 5368 

For the Company Secretary and Administrator 

Apex Administration (Guernsey) Limited

James Taylor

0203 530 3600

 

----------------------------------------------------------------------- 

 

Fund Description 

 

The objective of the Golden Prospect Precious Metals Fund is to provide investors with capital growth from a group of companies in the precious metals sector.

 

Portfolio Managers 

 

Keith Watson and Robert Crayfourd.

 

 

Key Advantages for the Investor 

· Access to under-researched mid and smaller companies in the precious metals sector

· Potential inflation protection from precious metals assets

· Low correlation to major asset classes 

 

Key Fund Facts1 

 

Total Gross Assets:

£34.50m 

Reference Currency:

GBP 

Ordinary Shares:

85,503,021

Net Asset Value:

36.08p 

Mid-Market Price:

31.00p 

Net gearing:

11.6% 

Discount:

(14.08%)

 

 

Ordinary Share and NAV Performance2 

 

 

One Month

Three Months

One Year

Three Years

Five Years

 

(%) 

(%) 

(%) 

(%) 

(%) 

NAV 

16.12 

(1.50) 

(4.65) 

(30.93)

31.53 

Share Price 

28.63 

5.08 

(6.06)

(31.03) 

51.96 

 

 

Commentary3 

 

Having lagged the move in gold and silver prices thus far in 2024, sentiment to miners showed a marked improvement with the Fund NAV rising over 16%. The Fund performance compared to a 21% sterling return registered by the Gold Bugs Index and the GDXJ equity ETF. However, we anticipate that the lag in performance of the smaller equities held in the Fund will catch-up with larger peers given their relatively attractive valuations.

 

Gold was one of the stronger commodities with the price rising over 9% during March to new all-time highs. Silver is latterly starting to catch-up, registering a 10% price increase over the month. Prices held despite a more hawkish move in US FED rate expectations after FOMC minutes indicated broader US labour markets were stubbornly resilient despite relatively tepid economic growth. Increasingly there appears to be a focus on ever growing government debt levels which have shown little sign of reversing, as evidence by the latest US congression Budget Office projections.

 

Recent physical gold buying has been led by China, with a pick-up in retail demand showing in import data. This has been potentially driven by broader concerns on the economy, particularly the weak regional property sector. Alongside this is the healthy net central bank demand: People's Bank of China (PBoC) data showed China's gold reserves continued to rise with the addition of 0.39 Moz in February taking official reserves to 72.6Moz (+10% year-on-year). Physical gold ETF's showed a pick-up in buying but aggregate holdings nevertheless ended 246k ounces lower over the month. We believe gold hitting all-time highs despite steady ETF selling is a positive, as would also be the case should ETF's turn steady buyers, further tightening the market.

 

West African Resources and Fortuna Gold and Silver were strong contributors to performance. This was closely followed by Australian gold producer Karora which received bid interest from ASX-listed Ramelius, as well as reports of a further interested party also in discussion with the company. While we do not focus our stock selection specifically on M&A targets, we believe quality undervalued assets should result in a higher probability of them becoming targets. The sector remains short of growth projects, and so we would anticipate a pick-up in M&A activity going forward. This should help close the discounts of junior miners to the larger. Calidus was the primary detractor to performance with the group undertaking an equity funding, in which the Fund participated, as part of a broader restructuring of its debt and gold hedging.

 

 

Gross Leverage5

(%)

Commitment Leverage6

(%)

Golden Prospect Precious Metals Limited 

111

111 

 

 

CQS (UK) LLP

4th Floor, One Strand, London WC2N 5HR, United Kingdom

T: +44 (0) 20 7201 6900 | F: +44 (0) 20 7201 1200

 

CQS (US), LLC

152 West 57th Street, 40th Floor, New York, NY 10019, US

T: +1 212 259 2900 | F: +1 212 259 2699

 

Tavistock Communications

18 St. Swithin's Lane, London EC4N 8AD

T: +44 20 7920 3150 | goldenprospect@tavistock.co.uk

 

Sources: 1,2 CQS as at the last business day of the month indicated at the top of this report. Performance is net of fees and expenses. New City Investment Managers took over the investment management function on 15 September 2008. These include historic returns and past performance is not a reliable indicator of future results. The value of investments can go down as well as up. Please read the Important Information section at the end of this document. 3 All market data is sourced from Bloomberg unless otherwise stated. The Fund may since have exited some / all the positions detailed in the commentary. 5 For methodology details see Article 4(3) of Directive 2011/61/EU (AIFMD) and Articles 6, 7, 9 and 10 of Delegated Regulation 231/2013. 6 For methodology details see Article 4(3) of Directive 2011/61/EU (AIFMD) and Articles 6, 8, 9, 10 and 11 of Delegated Regulation 231/2013.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCBXGDSIUDDGSL
Date   Source Headline
9th May 20242:05 pmRNSNet Asset Value(s)
8th May 202412:52 pmRNSNet Asset Value(s)
7th May 202412:39 pmRNSNet Asset Value(s)
3rd May 20241:32 pmRNSNet Asset Value(s)
2nd May 20242:40 pmRNSNet Asset Value(s)
1st May 20242:43 pmRNSNet Asset Value(s)
30th Apr 20242:22 pmRNSNet Asset Value(s)
29th Apr 202412:55 pmRNSNet Asset Value(s)
26th Apr 20243:01 pmRNSMonthly Investor Report - March 2024
26th Apr 20241:33 pmRNSNet Asset Value(s)
25th Apr 20241:02 pmRNSNet Asset Value(s)
24th Apr 20243:28 pmRNSNet Asset Value(s)
23rd Apr 202412:44 pmRNSNet Asset Value(s)
22nd Apr 20242:47 pmRNSNet Asset Value(s)
19th Apr 20243:26 pmRNSNet Asset Value(s)
18th Apr 20241:06 pmRNSNet Asset Value(s)
17th Apr 202412:40 pmRNSNet Asset Value(s)
16th Apr 20241:28 pmRNSNet Asset Value(s)
15th Apr 20242:24 pmRNSNet Asset Value(s)
12th Apr 20242:39 pmRNSNet Asset Value(s)
12th Apr 202411:40 amRNSAppointment of Adviser
11th Apr 202412:38 pmRNSNet Asset Value(s)
10th Apr 20242:34 pmRNSNet Asset Value(s)
9th Apr 202411:51 amRNSNet Asset Value(s)
8th Apr 20242:33 pmRNSNet Asset Value(s)
5th Apr 20241:01 pmRNSNet Asset Value(s)
4th Apr 20242:31 pmRNSNet Asset Value(s)
3rd Apr 20243:07 pmRNSNet Asset Value(s)
3rd Apr 20249:00 amRNSInvestment Manager
2nd Apr 20242:43 pmRNSNet Asset Value(s)
28th Mar 20242:18 pmRNSNet Asset Value(s)
27th Mar 20244:07 pmRNSDirector/PDMR Shareholding
27th Mar 20242:55 pmRNSNet Asset Value(s)
26th Mar 202412:04 pmRNSNet Asset Value(s)
25th Mar 20242:16 pmRNSNet Asset Value(s)
25th Mar 20247:00 amRNSAnnual Report and Audited Financial Statements
22nd Mar 202412:29 pmRNSNet Asset Value(s)
21st Mar 20243:17 pmRNSNet Asset Value(s)
20th Mar 202412:22 pmRNSNet Asset Value(s)
19th Mar 202411:46 amRNSNet Asset Value(s)
18th Mar 202412:07 pmRNSNet Asset Value(s)
15th Mar 202412:49 pmRNSNet Asset Value(s)
14th Mar 20242:15 pmRNSNet Asset Value(s)
13th Mar 202412:58 pmRNSNet Asset Value(s)
12th Mar 202412:10 pmRNSNet Asset Value(s)
11th Mar 20242:43 pmRNSNet Asset Value(s)
8th Mar 202412:42 pmRNSNet Asset Value(s)
7th Mar 202411:28 amRNSNet Asset Value(s)
6th Mar 202412:51 pmRNSNet Asset Value(s)
5th Mar 20243:25 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.